CML) need long-. Asciminib, a BCR::,-competitive tyrosine kinase inhibitors (TKIs).METHODSIn
mNSCLC) previously treated with platinum (PT)-based chemotherapy (chemo) and PD(L)-1inhibitors (IO
to EGFR Inhibitors in Lung Cancer. Cancer Discov. 2014;4(9):1046-1061.内容来源:阿斯利康中国